JournalArta
Wednesday, November 18, 2026 · JakartaS&P 7,303.98 ▼0.50%USD/IDR 18,245 ▼0.09%
JournalArta
Global Edition
beyond headlines
Advertisement

Sigma Healthcare Share Price Update: Little Changed, Up 5.5% in a Month

Technical analysis of Sigma Healthcare stock on November 18, 2026: price 2.90 AUD, trend uptrend, RSI 69.4, support 2.72, resistance 2.91.

By Alistair Sterling
November 18, 20265 min read
Sigma Healthcare Share Price Update: Little Changed, Up 5.5% in a Month
Logo Sigma Healthcare — JournalArta illustration
Sigma Healthcare last traded at 2.90 AUD on Wednesday, November 18, 2026 — flat on the day, and wedged just one cent below the top of its 20-session range. That is the number that matters first: a stock sitting at 95% of its 20-day range with an uptrend intact and almost no fresh money behind the move. The price is unchanged from the previous close, down 0.34% over five sessions, but up 5.45% over the past month. The signal is one of consolidation at altitude rather than a breakout in progress, and the shape of the tape — thin volume into resistance — is what deserves scrutiny.

Trend & Price Action

The structural picture is cleanly bullish. At 2.90, the stock sits above both the 20-day average at 2.81 and the 50-day average at 2.71, and the shorter average has been climbing, rising 0.73% over the past five days. That combination — price above the 50-day, 20-day above the 50-day, and a rising short-term average — is the textbook definition of an intact uptrend, and no fresh moving-average cross has formed, meaning the trend is established rather than newly minted. The 20-day average is providing a floor roughly 3% below the current price, and that is the level readers should watch if the consolidation breaks lower. The stock is also pressing the top of its three-month envelope. The resistance at 2.91 is one cent away, and the three-month high of 2.95 is just beyond it — conveniently close to the upper Bollinger band. That means the current price is doing exactly what a stock does before it either breaks out or rolls over: testing a ceiling on light participation.
Price action chart of Sigma Healthcare
3-month price action chart of Sigma Healthcare: price, SMA20/50, Bollinger, support & resistance.
Advertisement

Oscillators & Momentum

Momentum, however, is where the picture gets less comfortable. The RSI at 69.4 sits in what technical traders call the neutral zone but is threading the line just below overbought — a hair under the 70 threshold. More pointedly, the Stochastic is at 84.4 on both %K and %D, which is squarely overbought. For a general reader: these oscillators measure how far and how fast prices have moved, and readings this high mean the rally is getting stretched relative to its own recent history. It is not a sell signal on its own — in strong trends, oscillators can stay pinned high for weeks — but it does mean the easy part of the move has been captured. The counterweight is the MACD, which remains constructive: the MACD line at 0.050 sits above its signal at 0.044, with a positive histogram of 0.007. That is modest but genuine momentum confirmation, and it is not diverging from price. The tension between a positive MACD and an overbought Stochastic is the crux of the setup — the trend is real, but the runway for further immediate gains is short.
Momentum chart of Sigma Healthcare
Momentum chart of Sigma Healthcare: RSI(14), MACD, Stochastic.
Advertisement

Volatility & Volume

Volatility is in the middle of its range. The ATR of 0.05 is 1.7% of the share price, which translates to a stock that moves in modest daily increments, and Bollinger bandwidth of 10.1% is normal — neither a squeeze nor an expansion. The 20-day average slope and the width of the bands together suggest a market that is comfortable, not coiled. The volume line is the story's weak link. Last-session turnover of 10,277,885 shares was just 0.4 times the 20-day average of 23,408,646 — thin, by the data's own description. Thin volume into resistance is a classic warning: breakouts on light participation frequently fail. What keeps the bulls in the argument is the OBV, which continues to rise. On-balance volume tracks cumulative buying pressure, and a rising OBV alongside rising price says the accumulation that drove the 5.45% monthly gain is intact even if today's trade was quiet.
Advertisement

Key Levels & Scenarios

The map is straightforward. To the upside, a decisive close above 2.91 opens the path toward the three-month high of 2.95, with the Bollinger upper band in the same neighbourhood. A break above that would require volume to confirm — a breakout on 0.4× average is not a breakout, it is a drift. To the downside, the first line is the 20-day support at 2.72, which coincides closely with the Bollinger middle band at 2.81 and the 20-day average. Losing 2.72 would put the 50-day average at 2.71 in play, and a break there would call the uptrend itself into question.

Technical Verdict: BUY

The JournalArta research verdict on this stock is BUY, scored +66 on a −100 to +100 scale, and the reasoning holds up on inspection. Three points carry the call: price is above its 50-day average, the 20-day average is above the 50-day, and the trend is confirmed with RSI in the 50–70 constructive band. The positive MACD histogram and rising OBV reinforce it. The invalidation risk is explicit — the verdict fails if price breaks below the 2.81 stop level, and the overbought Stochastic is the main reason a trader would prefer to enter near the bottom of the range rather than the top.
  • Entry zone: 2.87 – 2.90
  • Exit target 1: 3.03
  • Exit target 2: 3.17
  • Stop loss: 2.81
  • Reward/risk: 1.4 / 3.0 | levels valid until 16 December 2026
Advertisement
In plain English: the trend is up, the stock is pressing its ceiling on quiet trade, and the setup favours patient accumulation on dips rather than chasing a breakout that has not yet arrived.

This is technical analysis for informational purposes only, not an investment recommendation. Past price behaviour does not guarantee future results.

Why Sigma Healthcare is in focus today

    Selected automatically from 9 ASX (Australia) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.

    Summary Data Sigma Healthcare

    Last price2.90 AUD
    Change 1 day / 5 days / 1 month0.00% / -0.34% / 5.45%
    Trend / MA-crossuptrend / none
    SMA20 / SMA502.81 / 2.71
    RSI (14) / Stochastic %K69.4 / 84.4
    Bollinger %B / ATR81% / 0.05
    Support / Resistance 20 days2.72 / 2.91
    Data as of18 November 2026 12:10 WIB
    JournalArta research verdict (score)Buy (+66)
    Entry zone2.87 – 2.90
    Target 1 / 23.03 / 3.17
    Stop loss2.81
    Reward/risk1.4 / 3.0
    Advertisement

    Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

    Advertisement
    Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
    Advertisement
    Most Read
    1. 1U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage
    2. 2Gold Silver Price November: Futures Rise Near Yearly Lows
    3. 3Michael Clarke Says Sandpapergate Scars Drew Steve Smith to New York
    4. 4GTA 6 New Zealand Time Trick Is Not Guaranteed to Work
    5. 5Sunrise on the Reaping Reviews Split Over Dark Hunger Games Prequel
    Advertisement
    Don't Miss

    Latest News

    All stories →
    1. Lifestyle · Food & HealthUS Loses Measles Elimination Status After 26 YearsNov 18
    2. Sport · More SportsUtah Mammoth Unveil Winter Classic Jersey for Outdoor DebutNov 18
    3. Sport · More SportsMariners’ Randy Arozarena Rejects Qualifying Offer, Enters Free AgencyNov 18
    4. Technology · AIUK MHRA Launches AdvanceGxP to Speed Up AI and Hospital-Made MedicinesNov 18
    5. Advertisement
    6. Lifestyle · EntertainmentFeige Says Marvel Planned Doctor Doom Before Majors ConvictionNov 18
    7. Lifestyle · Food & HealthResearchers Say Most Children Labeled Allergic to Penicillin Are NotNov 18
    8. Lifestyle · Food & HealthAt-Home Microbiome Tests Give Widely Different ResultsNov 18
    9. Technology · Apps & SoftwareWhat CNI Status Means for UK Data Centre OperatorsNov 18